Idexx Laboratories Stock Retained Earnings

IDXX Stock

USD 421.76 0.00 0.00%

IDEXX Laboratories fundamentals help investors to digest information that contributes to IDEXX Laboratories' financial success or failures. It also enables traders to predict the movement of IDEXX Stock. The fundamental analysis module provides a way to measure IDEXX Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IDEXX Laboratories stock.

	Last Reported	Projected for Next Year
Retained Earnings	4.4 B	4.7 B
Retained Earnings Total Equity	4.1 B	4.3 B

Retained Earnings is likely to rise to about 4.7 B in 2024. Retained Earnings Total Equity is likely to rise to about 4.3 B in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

IDEXX Laboratories Company Retained Earnings Analysis

IDEXX Laboratories' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Retained Earnings

Beginning RE + Income

-

Dividends

More About Retained Earnings | All Equity Analysis

Current IDEXX Laboratories Retained Earnings

4.44 B

Most of IDEXX Laboratories' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IDEXX Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

IDEXX Retained Earnings Driver Correlations

Understanding the fundamental principles of building solid financial models for IDEXX Laboratories is extremely important. It helps to project a fair market value of IDEXX Stock properly, considering its historical fundamentals such as Retained Earnings. Since IDEXX Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IDEXX Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IDEXX Laboratories' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.73	0.49	0.91	0.95	0.98	0.82	0.96	0.72	0.14	0.54	-0.89	0.98	0.6	0.8	0.62	0.05	0.72	0.85	-0.53	-0.46	0.79	0.71	0.7	0.69
Total Stockholder Equity	0.73		-0.22	0.89	0.59	0.74	0.2	0.69	0.61	-0.37	0.14	-0.56	0.68	0.09	0.5	0.0	0.52	0.14	0.47	-0.72	-0.44	0.77	0.79	0.8	0.73
Net Debt	0.49	-0.22		0.17	0.61	0.47	0.89	0.48	0.26	0.73	0.51	-0.5	0.53	0.64	0.49	0.82	-0.61	0.8	0.6	0.15	0.04	0.24	0.01	-0.08	0.09
Retained Earnings	0.91	0.89	0.17		0.84	0.92	0.55	0.83	0.76	-0.08	0.33	-0.84	0.88	0.42	0.74	0.33	0.33	0.45	0.73	-0.72	-0.44	0.87	0.76	0.71	0.74
Accounts Payable	0.95	0.59	0.61	0.84		0.96	0.86	0.87	0.74	0.18	0.53	-0.91	0.96	0.69	0.86	0.71	0.06	0.79	0.89	-0.55	-0.47	0.7	0.61	0.56	0.6
Net Receivables	0.98	0.74	0.47	0.92	0.96		0.79	0.91	0.72	0.07	0.46	-0.89	0.98	0.61	0.83	0.62	0.15	0.72	0.88	-0.65	-0.49	0.81	0.71	0.69	0.69
Total Liab	0.82	0.2	0.89	0.55	0.86	0.79		0.8	0.51	0.51	0.65	-0.8	0.84	0.78	0.72	0.89	-0.37	0.92	0.82	-0.16	-0.29	0.48	0.35	0.33	0.38
Total Current Assets	0.96	0.69	0.48	0.83	0.87	0.91	0.8		0.64	0.25	0.56	-0.78	0.91	0.48	0.69	0.57	-0.08	0.67	0.76	-0.34	-0.34	0.75	0.7	0.72	0.68
Intangible Assets	0.72	0.61	0.26	0.76	0.74	0.72	0.51	0.64		0.17	0.63	-0.8	0.67	0.39	0.84	0.32	0.34	0.37	0.61	-0.41	-0.24	0.57	0.51	0.3	0.35
Short Term Debt	0.14	-0.37	0.73	-0.08	0.18	0.07	0.51	0.25	0.17		0.48	-0.15	0.1	0.19	0.21	0.33	-0.75	0.3	0.18	0.56	0.61	0.11	-0.19	-0.42	-0.19
Common Stock	0.54	0.14	0.51	0.33	0.53	0.46	0.65	0.56	0.63	0.48		-0.64	0.52	0.61	0.66	0.56	-0.24	0.55	0.52	0.1	-0.19	0.1	0.16	0.08	-0.03
Treasury Stock	-0.89	-0.56	-0.5	-0.84	-0.91	-0.89	-0.8	-0.78	-0.8	-0.15	-0.64		-0.9	-0.79	-0.9	-0.69	-0.15	-0.73	-0.86	0.54	0.52	-0.59	-0.53	-0.47	-0.45
Property Plant Equipment	0.98	0.68	0.53	0.88	0.96	0.98	0.84	0.91	0.67	0.1	0.52	-0.9		0.69	0.81	0.68	0.03	0.77	0.89	-0.58	-0.53	0.76	0.66	0.66	0.67
Current Deferred Revenue	0.6	0.09	0.64	0.42	0.69	0.61	0.78	0.48	0.39	0.19	0.61	-0.79	0.69		0.74	0.89	-0.15	0.88	0.82	-0.32	-0.59	0.2	0.28	0.24	0.04
Good Will	0.8	0.5	0.49	0.74	0.86	0.83	0.72	0.69	0.84	0.21	0.66	-0.9	0.81	0.74		0.67	0.2	0.72	0.91	-0.51	-0.41	0.56	0.62	0.36	0.21
Long Term Debt	0.62	0.0	0.82	0.33	0.71	0.62	0.89	0.57	0.32	0.33	0.56	-0.69	0.68	0.89	0.67		-0.28	0.98	0.81	-0.16	-0.49	0.2	0.29	0.28	0.09
Net Tangible Assets	0.05	0.52	-0.61	0.33	0.06	0.15	-0.37	-0.08	0.34	-0.75	-0.24	-0.15	0.03	-0.15	0.2	-0.28		-0.26	0.01	-0.66	-0.43	0.11	0.33	0.32	0.16
Long Term Debt Total	0.72	0.14	0.8	0.45	0.79	0.72	0.92	0.67	0.37	0.3	0.55	-0.73	0.77	0.88	0.72	0.98	-0.26		0.88	-0.23	-0.52	0.33	0.43	0.4	0.2
Capital Surpluse	0.85	0.47	0.6	0.73	0.89	0.88	0.82	0.76	0.61	0.18	0.52	-0.86	0.89	0.82	0.91	0.81	0.01	0.88		-0.53	-0.5	0.62	0.69	0.51	0.3
Deferred Long Term Liab	-0.53	-0.72	0.15	-0.72	-0.55	-0.65	-0.16	-0.34	-0.41	0.56	0.1	0.54	-0.58	-0.32	-0.51	-0.16	-0.66	-0.23	-0.53		0.6	-0.6	-0.55	-0.56	-0.51
Short Long Term Debt	-0.46	-0.44	0.04	-0.44	-0.47	-0.49	-0.29	-0.34	-0.24	0.61	-0.19	0.52	-0.53	-0.59	-0.41	-0.49	-0.43	-0.52	-0.5	0.6		-0.08	-0.46	-0.68	-0.3
Long Term Investments	0.79	0.77	0.24	0.87	0.7	0.81	0.48	0.75	0.57	0.11	0.1	-0.59	0.76	0.2	0.56	0.2	0.11	0.33	0.62	-0.6	-0.08		0.67	0.55	0.73
Net Invested Capital	0.71	0.79	0.01	0.76	0.61	0.71	0.35	0.7	0.51	-0.19	0.16	-0.53	0.66	0.28	0.62	0.29	0.33	0.43	0.69	-0.55	-0.46	0.67		0.82	0.42
Net Working Capital	0.7	0.8	-0.08	0.71	0.56	0.69	0.33	0.72	0.3	-0.42	0.08	-0.47	0.66	0.24	0.36	0.28	0.32	0.4	0.51	-0.56	-0.68	0.55	0.82		0.69
Capital Stock	0.69	0.73	0.09	0.74	0.6	0.69	0.38	0.68	0.35	-0.19	-0.03	-0.45	0.67	0.04	0.21	0.09	0.16	0.2	0.3	-0.51	-0.3	0.73	0.42	0.69

Click cells to compare fundamentals

Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

Competition

Predict IDEXX Laboratories

Retained Earnings Over Time

Based on the latest financial disclosure, IDEXX Laboratories has a Retained Earnings of 4.44 B. This is 377.21% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The retained earnings for all United States stocks is 52.36% higher than that of the company.

IDEXX Retained Earnings Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IDEXX Laboratories' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics of similar companies.

IDEXX Laboratories is currently under evaluation in retained earnings category among its peers.

IDEXX Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.

Environmental

Governance

Social

IDEXX Fundamentals

	Return On Equity	0.59
	Return On Asset	0.23
	Profit Margin	0.23 %
	Operating Margin	0.37 %
	Current Valuation	34.86 B
	Shares Outstanding	81.88 M
	Shares Owned By Insiders	0.94 %
	Shares Owned By Institutions	94.22 %
	Number Of Shares Shorted	2.08 M
	Price To Earning	61.31 X
	Price To Book	21.12 X
	Price To Sales	8.89 X
	Revenue	3.66 B
	Gross Profit	2 B
	EBITDA	1.1 B
	Net Income	845.04 M
	Cash And Equivalents	114.36 M
	Cash Per Share	1.37 X
	Total Debt	1.07 B
	Debt To Equity	3.27 %
	Current Ratio	0.89 X
	Book Value Per Share	19.72 X
	Cash Flow From Operations	906.51 M
	Short Ratio	2.06 X
	Earnings Per Share	10.35 X
	Price To Earnings To Growth	4.39 X
	Target Price	476.76
	Number Of Employees	11 K
	Beta	1.36
	Market Capitalization	34.17 B
	Total Asset	3.26 B
	Retained Earnings	4.44 B
	Working Capital	543.71 M
	Current Asset	821.63 M
	Current Liabilities	856.76 M
	Net Asset	3.26 B

About IDEXX Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IDEXX Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC